FDA approves Wegovy GLP-1 pill, pushing weight-loss drugs into new era

Watch FDA approves Wegovy GLP-1 pill, pushing weight-loss drugs into new era - Straight Arrow News on Dailymotion

Transcript

00:00A major breakthrough in the weight loss drug boom.

00:05The FDA has approved the first ever GLP-1 pill to treat obesity.

00:11The drug is made by Novo Nordisk, the maker of Wagovi, and is expected to hit the market in early 2026.

00:17It will be available through pharmacies and health providers.

00:20Novo Nordisk says the daily 1.5 milligram pill will cost about $149 a month,

00:26but significantly less than many injectable options.

00:30The company has already struck a deal with the Trump administration to offer the pill through TrumpRx,

00:35a new platform expected to launch in the new year.

00:38The pill uses the same active ingredient as Wagovi, semaglutide,

00:43which mimics a hormone in the body that reduces appetite and increases feelings of fullness.

00:49Health experts say the pill could open the door to a whole new group of patients,

00:52especially people who want the benefits of GLP-1s but don't want injections.

00:58According to CNBC, about one in eight adults is now taking a GLP-1 drug for weight loss or conditions like diabetes.

01:07Analysts estimate the weight loss drug market could reach $100 billion in the coming years.

01:12And competition is coming fast.

01:14Eli Lilly, the maker of ZepBound, is also expected to release its own GLP-1 weight loss pill sometime soon.

01:24triOk Cecilia